Event Type
Disclosure
Voluntary
Variant
8-K
, including Exhibit 99.1, shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act or into any fi
. Financial Statements and Exhibits. (d) Exhibits: Exhibit No. Description 99.1 Emergent BioSolutions Inc. Investor Presentation, dated January 14, 2026 104 Cov